Three Amigos Stock Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sergio H who wrote (18190)	1/4/2000 9:55:00 PM
From: Amigo Mike	Read Replies (1) of 29382

Hi Amigo, As you are aware, CYPB is one of my old favorites. It has been beaten up along with many other bios. The market is waiting for the ramp on sales of the Prosorba Column. We had a nice run in the stock (nice $$ for the Amigos) when the Prosorba Column received it approvals .... but there has yet to be any significant sales. The company also has a product in development called Cyplex which is generally an alternative to blood platelets. This product is in Phase II (don't quote me) but may also be being held up pending sales of Prosorba column for further funding. Cyplex is expected to be a big revenue producer if it gets FDA Approvals. Noticed today that there is a board shake up. Not sure whether or not this is good or bad at the moment. I would rate this a hold at best right now pending data on Prosorba ramp. Amigo Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next